Vera Therapeutics' Phase 3 data on atacicept sparks optimism for IgAN treatment, but competition and market challenges may ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced three leadership appointments. Brian Gorman joins Hansa as Chief Legal Officer ...

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1 30 Jun 2025 OSAKA, Japan & CAMBRIDGE, Mass.

Recommendation based on Phase 3 RATIONALE-315 study, in which TEVIMBRA demonstrated clinically meaningful and statistically significant improvement in event-free survival and major pathological respon ...

Check out our PLTR stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

As Howie Roseman and the Philadelphia Eagles endlessly tweak their roster, we'll update the Birds' depth chart (as we see it) every time they make a move this offseason and into the regular season.